# Biohm Technologies

> Biohm Technologies is a Cleveland-based microbiome innovation company that studies the gut as a whole - bacteria and fungi together - rather than bacteria alone. Built on 40+ years of fungal research by Dr. Mahmoud Ghannoum, the scientist who named the mycobiome, Biohm develops data-driven biotic ingredients and gut-health testing solutions. Its flagship ingredient Mycohsa is the first probiotic blend clinically shown to break down digestive biofilms, and its Symbiont discovery platform mines a large bacterial-fungal dataset to design targeted microbiome products. After a B2B pivot in 2024, the company now sells ingredients and microbiome science to nutraceutical and food brands.

- **Founded:** 2016
- **Headquarters:** Cleveland, Ohio, United States
- **Founders:** Afif Ghannoum (Co-Founder (original BIOHM Health brand)), Dr. Mahmoud Ghannoum (Co-Founder & Chief Scientific Officer), Sam Schatz (CEO & Co-Founder)
- **Team size:** ~25 employees
- **Products:** Mycohsa, Phorum, Gut Microbiome Test Kits, Symbiont Platform
- **Notable:** Mycohsa is the first data-powered probiotic blend clinically shown to break down digestive biofilms., Built on 40+ years of NIH-funded research by Dr. Mahmoud Ghannoum, who coined the term 'mycobiome'., Dr. Ghannoum has published 600+ peer-reviewed papers cited 46,000+ times.

## Products & services

- **Mycohsa** — Flagship probiotic blend combining bacterial and fungal communities with a digestive enzyme; clinically studied to break down digestive biofilms and support balanced gut levels of bacteria and yeasts.
- **Phorum** — Next-generation postbiotic containing bacteria and fungi to support gut immune function.
- **Gut Microbiome Test Kits** — At-home sequencing kits analyzing both fungal and bacterial species, returning personalized nutrition, lifestyle and supplement recommendations.
- **Symbiont Platform** — Bioinformatic discovery engine that mines Biohm's bacterial-fungal microbiome dataset to design and validate targeted microbiome ingredients for partner brands.

## Achievements

- Mycohsa is the first data-powered probiotic blend clinically shown to break down digestive biofilms.
- Built on 40+ years of NIH-funded research by Dr. Mahmoud Ghannoum, who coined the term 'mycobiome'.
- Dr. Ghannoum has published 600+ peer-reviewed papers cited 46,000+ times.
- Three published human clinical studies supporting Mycohsa.
- 2018 NBJ Award for Science and Innovation.
- 2023 NutraIngredients-USA Microbiome Modulation Product of the Year.
- Health Canada NPN approval for Mycohsa (2026).
- Opened Atlanta R&D lab at Portal Innovations' Science Square in November 2025.

## Latest updates

- **2024-10** — Unveiled new corporate brand identity as Biohm Technologies, signaling a strategic pivot to B2B microbiome solutions.
- **2025-02** — Closed $4.52M Series B (B-IV tranche) with investors including Praesidium, Sparkfood by Sonae and Forte Ventures.
- **2025-04** — Announced new VP of Science and Technology, Dr. John Deaton, alongside fresh funding.
- **2025-11** — Opened R&D lab at Portal Innovations' Science Square in Atlanta to accelerate fungal microbiome ingredient development.

## Links

- Website: https://biohmtechnologies.com
- LinkedIn: https://www.linkedin.com/company/biohm-technologies
- Twitter/X: https://twitter.com/biohmhealth
- Instagram: https://instagram.com/biohmhealth
- Facebook: https://facebook.com/biohmhealth

---

Profile page: https://yespress.io/biohm-technologies
Published by YesPress — https://yespress.io
Last updated: 2026-06-07